Product Program year 2021 Source: CMS Open Payments

Proclaim XR IPG

Device Neuromodulation

PDI 05415067031426

Open in the dashboard

General payments

$43,183

650 payments

Research payments

$3,499,278

617 payments

Through program year 2021, $43,183 in general payments and $3,499,278 in research payments were reported against Proclaim XR IPG (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $43,183 650
2021 Research $3,499,278 617

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $43,183 650 payments
Top recipients General payments · program year 2021
  1. Allegheny General Hospital Teaching hospital · PA $7,500 17% · 1 payment
  2. Timothy Deer Interventional Pain Medicine · Charleston, WV $4,270 10% · 5 payments
  3. Steven Falowski Neurological Surgery · Fountain Hill, PA $3,906 9% · 3 payments
  4. David Lee Interventional Pain Medicine · Yorba Linda, CA $2,600 6% · 1 payment
  5. Derron Wilson Pain Medicine · Carmel, IN $2,338 5% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Pain Medicine Pain Medicine $12,760 36% · 44 practitioners
  2. Neurological Surgery $6,226 17% · 22 practitioners
  3. Pain Medicine Anesthesiology $6,070 17% · 34 practitioners
  4. Pain Medicine $2,134 6% · 10 practitioners
  5. Physician Assistant $1,574 4% · 17 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Pennsylvania $14,547 34% · 19 recipients
  2. California $4,310 10% · 8 recipients
  3. West Virginia $4,270 10% · 1 recipient
  4. Louisiana $3,388 8% · 39 recipients
  5. Texas $3,177 7% · 19 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

650 general · 617 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record